CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 180 participants.
Also called NCT02816762
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 180 participants
- Registry
-
NCT02816762
-
- Other papers using this trial's data
- Continuous Positive Airway Pressure Effect on Albuminuria Progression in Patients with Obstructive Sleep Apnea and Diabetic Kidney Disease: A Randomized Clinical Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT02816762. Randomized; no masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2020-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea
- Acronym
- DIANA
- Condition
- Diabetic Nephropathy
- Condition
- Sleep Apnea
- Intervention (Device)
- Continuous positive airway pressure
- Intervention (Drug)
- Pharmacological treatment
- Intervention (Other)
- Diet
- Lead sponsor
- Hospital Universitario La Paz
Record details
- Record id
cardio:ct-nct02816762- Content hash
ad73af1f99d8f3217f812ae1fcb5c1a3a0ef684540bce7dd986f573af955a5a9